Paper Review Records
全部论文审稿周期
13 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
143
天
Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapy
作者
Xiaojing Zhu; Yutong Xing; Wenrui Jin; Haoran Geng; Fan Li; Yeying Li; Hongtao Zhang; Chengjun Wu; Chen Chen; Zhenyong Wu展开收起
作者单位
College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China; School of Life and Health Sciences, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao 266113, China; Department of Neurosurgery, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai 264000, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天